Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 20/20 | 0.54 |
| ▸ | CTSS | P25774 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22886642 | 1.00 | CAPN1 (0.54) | CAPN1CTSS | |
| SCHEMBL29962127 | 0.89 | CAPN1 (0.55) | CAPN1CTSS | |
| SCHEMBL22886441 | 0.89 | CAPN1 (0.55) | CAPN1CTSS | |
| SCHEMBL20028406 | 0.88 | CAPN1 (0.54) | CAPN1CTSS | |
| SCHEMBL21854267 | 0.86 | CAPN1 (0.54) | CAPN1CTSS | |
| SCHEMBL21854219 | 0.86 | CAPN1 (0.52) | CAPN1CTSS | |
| SCHEMBL20028487 | 0.85 | CAPN1 (0.58) | CAPN1CTSS | |
| SCHEMBL20027773 | 0.85 | CAPN1 (0.57) | CAPN1CTSS | |
| SCHEMBL21854128 | 0.85 | CAPN1 (0.57) | CAPN1CTSS | |
| SCHEMBL21854248 | 0.85 | CAPN1 (0.57) | CAPN1CTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220347173-A1 | METHODS OF TREATING LIVER FIBROSIS USING CALPAIN INHIBITORS | BLADE THERAPEUTICS INC (US) | 2022-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220347173-A1 | METHODS OF TREATING LIVER FIBROSIS USING CALPAIN INHIBITORS | CAPNS1, CAPN9, CAPN2 | CAPN1 4/4885CTSS 47/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.